Biovie Inc (BIVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,099 | 20,541 | 24,978 | 17,545 | 23,152 |
| Receivables | 2,174 | 196 | 180 | 2,104 | N/A |
| Other current assets | 1,607 | 1,055 | 874 | 1,050 | 570 |
| TOTAL | $16,880 | $21,791 | $26,032 | $20,699 | $23,722 |
| Non-Current Assets | |||||
| Intangibles | 352 | 409 | 467 | 524 | 581 |
| Other Non-Current Assets | 283 | 303 | 321 | 340 | 357 |
| TOTAL | $635 | $712 | $788 | $864 | $939 |
| Total Assets | $17,515 | $22,503 | $26,820 | $21,562 | $24,660 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,611 | 2,923 | 1,566 | 2,200 | 2,476 |
| TOTAL | $1,694 | $3,006 | $1,645 | $2,275 | $2,547 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 213 | 233 | 254 | 275 | 296 |
| TOTAL | $213 | $233 | $254 | $275 | $296 |
| Total Liabilities | $1,907 | $3,238 | $1,899 | $2,550 | $2,842 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,542 | 7,544 | 7,540 | 7,534 | 1,856 |
| Common Shares | 1 | 1 | 1 | 0 | 8 |
| Retained earnings | -368,615 | -363,345 | -357,275 | -352,144 | -348,655 |
| TOTAL | $15,608 | $19,265 | $24,921 | $19,012 | $21,818 |
| Total Liabilities And Equity | $17,515 | $22,503 | $26,820 | $21,562 | $24,660 |